Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inflammatory disorder of the cilliary body in the uvea that affects healthy, younger individuals who are often asymptomatic. It has a long clinical course with relapses and remissions. Symptoms include mildly decreased vision and floaters. It may be associated with autoimmune disorders.
Biomarker and diagnostic research for pars planitis has been reported in the published literature.
No clinical trials have been registered for pars planitis.
66 publications have been identified in PubMed for pars planitis. Research spans Case Report / Case Series (36%), Epidemiology / Natural History (21%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 | 36% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:03 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
14 |
21% |
Clinical study results | 13 | 20% |
Laboratory research | 6 | 9% |
Research summaries | 5 | 8% |
Testing and diagnosis research | 3 | 5% |
New treatment approaches | 1 | 2% |
Khan N (2026). [PMID: 41943391](https://pubmed.ncbi.nlm.nih.gov/41943391/). *Ocul Immunol Inflamm*. [Epidemiology / Natural History]
Daw W (2026). [PMID: 41798516](https://pubmed.ncbi.nlm.nih.gov/41798516/). *Cureus*. [Review / Meta-Analysis]
Isik Eker P (2026). [PMID: 42202703](https://pubmed.ncbi.nlm.nih.gov/42202703/). *J Fr Ophtalmol*. [Epidemiology / Natural History]
Jiang C (2026). [PMID: 42051734](https://pubmed.ncbi.nlm.nih.gov/42051734/). *Front Med (Lausanne)*. [Case Report / Case Series]
Murata N (2026). [PMID: 42018117](https://pubmed.ncbi.nlm.nih.gov/42018117/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Daniel R (2026). [PMID: 41498315](https://pubmed.ncbi.nlm.nih.gov/41498315/). *Indian journal of ophthalmology*. [Clinical Trial Publication]
Abdullatif AM (2026). [PMID: 41417954](https://pubmed.ncbi.nlm.nih.gov/41417954/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Korntner S (2026). [PMID: 41971247](https://pubmed.ncbi.nlm.nih.gov/41971247/). *J Vitreoretin Dis*. [Case Report / Case Series]
Ardizzone D (2026). [PMID: 41844186](https://pubmed.ncbi.nlm.nih.gov/41844186/). *Klin Monbl Augenheilkd*. [Case Report / Case Series]
Xia JL (2026). [PMID: 41570308](https://pubmed.ncbi.nlm.nih.gov/41570308/). *Retina (Philadelphia, Pa.)*. [Clinical Trial Publication]